Press Releases Investors Overview News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts Company Info Overview Management Team Clinical Advisory Board Medical Consultants Presentations Contacts FAQ Financial Info Overview Balance Sheet Income Statement Cash Flow Financial Results Stock Data Quote Charts Historical Data SEC Filings Overview All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Overview Board of Directors Board Committees Governance Documents Investor Tools Email Alerts Tear Sheet Investor Presentation Contacts RSS News Feed News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 All Releases Financial Releases Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia Sep 23, 2021 Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference Sep 7, 2021 Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update Aug 12, 2021 Viveve to Host Conference Call on August 12, 2021 to Report Second Quarter Financial Results and Provide Corporate Update Aug 5, 2021 Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent Aug 3, 2021 Viveve Announces New Category III CPT Code for its Stress Urinary Incontinence Procedure Jul 7, 2021 Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference Jul 6, 2021 Viveve Announces Issuance of New Device and Methods Patent in U.S. Jun 10, 2021 Viveve Announces Adjournment of Annual Meeting Jun 2, 2021 Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update May 13, 2021 1 2 3 4 5 6 7 8 9 10 ...32
Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia Sep 23, 2021
Viveve to Host Conference Call on August 12, 2021 to Report Second Quarter Financial Results and Provide Corporate Update Aug 5, 2021
